Pedro V Baptista Selected Research

Pedro V Baptista Research Topics

Disease

40	Neoplasms (Cancer) 03/2022 - 02/2010
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2014
7	Carcinoma (Carcinomatosis) 01/2022 - 10/2018
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021 - 02/2010
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2018
3	Adenocarcinoma 02/2021 - 05/2015
2	Lung Neoplasms (Lung Cancer) 03/2022 - 10/2013
2	Inflammation (Inflammations) 01/2022 - 05/2015
2	Breast Neoplasms (Breast Cancer) 02/2021 - 01/2017
2	Hyperthermia 01/2021 - 09/2020
2	Leukemia 01/2019 - 01/2017
2	Philadelphia Chromosome 11/2018 - 07/2016
2	Malaria 08/2015 - 01/2012
2	Tuberculosis (Tuberculoses) 08/2015 - 01/2011
1	Reperfusion Injury 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Ischemia 01/2022
1	Disease Progression 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 03/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Necrosis 02/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Circulating Neoplastic Cells 01/2019
1	Adenocarcinoma of Lung 10/2018
1	Carcinogenesis 01/2017
1	Lymphoma (Lymphomas) 01/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 03/2016
1	Hepatocellular Carcinoma (Hepatoma) 09/2015

Drug/Important Bio-Agent (IBA)

26	GoldIBA 07/2021 - 02/2010
8	Biological ProductsIBA 03/2021 - 01/2011
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2019
5	Proteins (Proteins, Gene)FDA Link 11/2021 - 08/2014
5	Pharmaceutical PreparationsIBA 11/2019 - 06/2014
4	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 09/2015
3	Tumor Biomarkers (Tumor Markers)IBA 03/2022 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 03/2013 - 02/2010
2	ErbB Receptors (EGF Receptor)IBA 11/2021 - 10/2017
2	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 10/2020
2	Peptides (Polypeptides)IBA 03/2021 - 01/2017
2	SilverIBA 01/2021 - 10/2019
2	Nucleic AcidsIBA 07/2020 - 06/2017
2	Cetuximab (Erbitux)FDA Link 11/2019 - 06/2014
2	MicroRNAs (MicroRNA)IBA 01/2019 - 03/2013
2	LigandsIBA 10/2018 - 09/2015
2	NanoconjugatesIBA 06/2017 - 10/2013
2	OligonucleotidesIBA 01/2017 - 08/2014
2	Small Interfering RNA (siRNA)IBA 05/2015 - 10/2013
1	Liposomes (Liposome)IBA 01/2022
1	QuercetinIBA 01/2022
1	TriazolesIBA 01/2022
1	AcridinesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	beta CateninIBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021
1	NF-kappa B (NF-kB)IBA 11/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2021
1	Amyloid beta-PeptidesIBA 03/2021
1	TrabectedinIBA 01/2021
1	MetalsIBA 01/2021
1	OxidesIBA 01/2021
1	GraphiteIBA 01/2021
1	OxindolesIBA 01/2021
1	Oxygen (Dioxygen)IBA 10/2020
1	HalogensIBA 10/2020
1	IronIBA 09/2020
1	Annexin A5IBA 02/2020
1	FormazansIBA 02/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2019
1	SaltsIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 11/2018
1	PropaneIBA 10/2018
1	ethyleneIBA 10/2018
1	AcetyleneIBA 10/2018
1	bis(diphenylphosphine)ethane (bis(diphenylphosphino)ethane)IBA 10/2018
1	Diacetyl (Biacetyl)IBA 10/2018
1	tesmilifene (DPPE)IBA 10/2018
1	nonaneIBA 10/2018
1	Monoclonal AntibodiesIBA 10/2017
1	PhenanthrolinesIBA 10/2017
1	Imatinib Mesylate (Gleevec)FDA Link 06/2017
1	Tyrosine Kinase InhibitorsIBA 06/2017
1	Antisense DNAIBA 01/2017
1	A-factor (Streptomyces)IBA 01/2017
1	benzamideIBA 03/2016
1	TubulinIBA 03/2016
1	AcidsIBA 03/2016
1	CopperIBA 09/2015
1	LuciferasesIBA 05/2015
1	Glucose (Dextrose)FDA LinkGeneric 05/2015

Therapy/Procedure

15	Therapeutics 01/2021 - 11/2015
5	Drug Therapy (Chemotherapy) 10/2020 - 01/2017
3	Lasers (Laser) 10/2020 - 11/2017
3	Precision Medicine 01/2017 - 11/2014
2	Photothermal Therapy 01/2017 - 11/2014
1	Induced Hyperthermia (Thermotherapy) 10/2020
1	Phototherapy (Light Therapy) 11/2017